2010Practical Preventive MedicineRequires access

Analysis of Drug Resistance and β-Lactamases in Acinetobacter baumannii

HU Fang-xing

Open publisher page 0 citations

Abstract

Objective To investigate the drug resistance and β-lactamases in clinical isolates Acinetobacter baumannii in the Third Hospital of Changsha. Methods The drug sensitivity was performed by K-B method. The ESBLs enzyme and AmpC enzyme were detected by phenotypic confirmatory test and phenotypic screening method,respectively. Results The resistance rates of 86 strains of Acinetobacter baumannii to ampicillin/sulbactam,cefoperazone/sulbactam,imipenem and meropenem were 25.6%,9.2%,17.4% and 15.1%,respectively,but to other 10 kinds of antibiotics were higher (39.5%~67.4%). 21 strains (24.4%) were found to produce ESBLs and 31 strains (36.0%) were found to produce AmpC enzyme. Conclusions The drug resistant rate of Acinetobacter baumannii is high in the Third Hospital of Changsha,so drug susceptibility test should be enforced to guide clinicians applying antibiotics reasonably; its resistance to β-lactam drug is related to ESBLs and AmpC enzymes.

About this research paper

What this paper is about

Objective To investigate the drug resistance and β-lactamases in clinical isolates Acinetobacter baumannii in the Third Hospital of Changsha. Methods The drug sensitivity was performed by K-B method. The ESBLs enzyme and AmpC enzyme were detected by phenotypic confirmatory test and phenotypic screening method,respectively. Results The resistance rates of 86 strains of Acinetobacter baumannii to ampicillin/sulbactam,cefoperazone/sulbactam,imipenem and meropenem were 25.6%,9.2%,17.4% and 15.1%,respectively,but to other 10 kinds of antibiotics were higher (39.5%~67.4%). 21 strains (24.4%) were found to produce ESBLs and 31 strains (36.0%) were found to produce AmpC enzyme. Conclusions The drug resistant rate of Acinetobacter baumannii is high in the Third Hospital of Changsha,so drug susceptibility test should be enforced to guide clinicians applying antibiotics reasonably; its resistance to β-lactam drug is related to ESBLs and AmpC enzymes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the drug resistance and β-lactamases in clinical isolates Acinetobacter baumannii in the Third Hospital of Changsha. Methods The drug sensitivity was performed by K-B method. The ESBLs enzyme and AmpC enzyme were detected by phenotypic confirmatory test and phenotypic screening method,respectively. Results The resistance rates of 86 strains of Acinetobacter baumannii to ampicillin/sulbactam,cefoperazone/sulbactam,imipenem and meropenem were 25.6%,9.2%,17.4% and 15.1%,respectively,but to other 10 kinds of antibiotics were higher (39.5%~67.4%). 21 strains (24.4%) were found to produce ESBLs and 31 strains (36.0%) were found to produce AmpC enzyme. Conclusions The drug resistant rate of Acinetobacter baumannii is high in the Third Hospital of Changsha,so drug susceptibility test should be enforced to guide clinicians applying antibiotics reasonably; its resistance to β-lactam drug is related to ESBLs and AmpC enzymes.

Key concepts: Sulbactam, Acinetobacter baumannii, Cefoperazone, Meropenem, Imipenem, Microbiology, Drug resistance, Ampicillin

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of Drug Resistance and β-Lactamases in Acinetobacter baumannii — Research Paper | ScholarLens